Douglas Bernhard Selected Research

Dystonia (Limb Dystonia)

1/2023	Striatal Subregion-selective Dysregulated Dopamine Receptor-mediated Intracellular Signaling in a Model of DOPA-responsive Dystonia.
6/2013	Subtle microstructural changes of the striatum in a DYT1 knock-in mouse model of dystonia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Douglas Bernhard Research Topics

Disease

4	Parkinson Disease (Parkinson's Disease) 12/2023 - 04/2016
2	Dystonia (Limb Dystonia) 01/2023 - 06/2013
1	Dopa-responsive Dystonia 01/2023
1	Movement Disorders (Movement Disorder) 01/2023
1	Parkinsonian Disorders (Parkinsonism) 01/2023
1	Phenylketonurias (Phenylketonuria) 07/2013
1	Dystonia musculorum deformans type 1 06/2013
1	Dystonic Disorders (Writer's Cramp) 06/2013

Drug/Important Bio-Agent (IBA)

2	Levodopa (L Dopa)FDA LinkGeneric 01/2023 - 01/2019
1	Phosphotransferases (Kinase)IBA 01/2023
1	Dopamine (Intropin)FDA LinkGeneric 01/2023
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2023
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2023
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2023
1	Dopamine AntagonistsIBA 01/2023
1	RacloprideIBA 01/2023
1	Uric Acid (Urate)IBA 04/2016
1	Neurotransmitter Agents (Neurotransmitter)IBA 07/2013
1	Phenylalanine (L-Phenylalanine)FDA Link 07/2013
1	sapropterin (tetrahydrobiopterin)FDA Link 07/2013
1	Codon (Codons)IBA 06/2013

Therapy/Procedure

2	Therapeutics 01/2019 - 07/2013
1	Deep Brain Stimulation 12/2023